BioGene Therapeutics Inc.
through Aug 7, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Aug 6, 2026 · D | Aug 7, 2026 · D | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $3,000,000 | $3,000,000 | $0 |
| Reported amount sold | $3,000,000 | $3,000,000 | $0 |
| Reported investor count | 1 | 1 | 0 |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0002140719-26-000004 · Later SEC source: 0002140719-26-000005
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $3,000,000
- Reported amount sold
- $3,000,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (5)
-
0002140719-26-000005D · Aug 7, 2026 · BiotechnologyOffering: $3,000,000Sold: $3,000,000
-
0002140719-26-000004D · Aug 6, 2026 · BiotechnologyOffering: $3,000,000Sold: $3,000,000
-
0002140719-26-000003D · Aug 6, 2026 · BiotechnologyOffering: $250,000Sold: $250,000
-
0002140719-26-000002D · Aug 6, 2026 · BiotechnologyOffering: $250,000Sold: $250,000
-
0002140719-26-000001D · Jul 23, 2026 · BiotechnologyOffering: $4,550,000Sold: $4,550,000